MiNK Therapeutics (INKT) Short Interest Ratio & Short Volume $13.61 -0.73 (-5.09%) Closing price 04:00 PM EasternExtended Trading$14.00 +0.39 (+2.87%) As of 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MiNK Therapeutics Short Interest DataMiNK Therapeutics (INKT) has a short interest of 48,600 shares, representing 4.42% of the float (the number of shares available for trading by the public). This marks a -32.87% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 45,518 shares to cover all short positions.Current Short Interest48,600 sharesPrevious Short Interest72,400 sharesChange Vs. Previous Month-32.87%Dollar Volume Sold Short$692.06 thousandShort Interest Ratio0.1 Days to CoverLast Record DateAugust 31, 2025Outstanding Shares4,520,000 sharesFloat Size1,100,000 sharesShort Percent of Float4.42%Today's Trading Volume44,411 sharesAverage Trading Volume45,518 sharesToday's Volume Vs. Average98% Short Selling MiNK Therapeutics? Sign up to receive the latest short interest report for MiNK Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINKT Short Interest Over TimeINKT Days to Cover Over TimeINKT Percentage of Float Shorted Over Time MiNK Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/202548,600 shares $692.06 thousand -32.9%4.4%0.1 $14.24 8/15/202572,400 shares $1.08 million +104.5%6.5%0.1 $14.91 7/31/202535,400 shares $536.66 thousand -85.9%3.6%0 $15.16 7/15/2025250,900 shares $7.03 million +1,845.0%25.3%0.3 $28.01 6/30/202512,900 shares $94.69 thousand +20.6%1.3%1.7 $7.34 6/15/202510,700 shares $78.22 thousand -10.8%1.1%1.3 $7.31 5/31/202512,000 shares $83.76 thousand -45.5%1.2%2.1 $6.98 5/15/202522,000 shares $163.90 thousand -3.9%2.2%3.1 $7.45 4/30/202522,900 shares $173.47 thousand -13.6%2.3%2.6 $7.58 4/15/202526,500 shares $205.38 thousand +10.4%2.7%1 $7.75 Get the Latest News and Ratings for INKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/31/202524,000 shares $207.36 thousand -17.8%2.4%0.8 $8.64 3/15/202529,200 shares $247.91 thousand +9.0%2.9%0.9 $8.49 2/28/202526,800 shares $239.86 thousand -12.7%2.7%0.8 $8.95 2/15/202530,700 shares $291.65 thousand +104.7%3.1%1 $9.50 1/31/202515,000 shares $137.40 thousand -0.7%1.5%0.5 $9.16 1/15/202515,100 shares $131.35 thousand -87.7%0.2%1.4 $8.70 12/31/2024123,000 shares $85.72 thousand +160.6%1.2%1.3 $0.70 12/15/202447,200 shares $29.08 thousand +9.8%0.5%1 $0.62 11/30/202443,000 shares $31.52 thousand -15.2%0.4%1.1 $0.73 11/15/202450,700 shares $38.23 thousand -1.9%0.5%1.4 $0.75 10/31/202451,700 shares $36.91 thousand -20.8%0.5%1.5 $0.71 10/15/202465,300 shares $43.42 thousand +34.4%0.7%1.7 $0.67 9/30/202448,600 shares $36.45 thousand -21.6%0.5%0.8 $0.75 9/15/202462,000 shares $48.08 thousand +22.5%0.6%1.2 $0.78 8/31/202450,600 shares $40.99 thousand -21.3%0.5%0.9 $0.81 8/15/202464,300 shares $52.79 thousand +5.1%1.1%1 $0.82 7/31/202461,200 shares $57.53 thousand -27.9%1.2%0.4 $0.94 7/15/202484,900 shares $96.79 thousand -10.3%1.6%0.6 $1.14 6/30/202494,600 shares $89.79 thousand -19.6%1.8%0.6 $0.95 6/15/2024117,600 shares $108.16 thousand -31.4%2.2%0.6 $0.92 5/31/2024171,300 shares $166.16 thousand -66.9%3.2%0.9 $0.97 5/15/2024516,900 shares $537.58 thousand +490.7%5.2%2.8 $1.04 4/30/202487,500 shares $86.63 thousand +80.4%0.9%0.9 $0.99 4/15/202448,500 shares $44.06 thousand +18.0%0.5%0.5 $0.91 3/31/202441,100 shares $37.33 thousand -11.6%0.4%0.4 $0.91 3/15/202446,500 shares $41.59 thousand +12.6%0.5%0.8 $0.89 2/29/202441,300 shares $38.05 thousand -76.4%0.4%0.7 $0.92 2/15/2024175,100 shares $162.84 thousand -7.6%1.8%3.4 $0.93 1/31/2024189,400 shares $163.83 thousand +8.3%2.0%3.8 $0.87 1/15/2024174,900 shares $172.98 thousand -1.7%1.8%3.8 $0.99 12/31/2023178,000 shares $190.46 thousand +237.8%1.9%4.6 $1.07 12/15/202352,700 shares $53.75 thousand -66.3%0.6%1.2 $1.02 11/30/2023156,400 shares $164.22 thousand +2.4%1.6%3.9 $1.05 11/15/2023152,700 shares $155.75 thousand -19.7%1.6%3.4 $1.02 10/31/2023190,100 shares $193.90 thousand +11.7%2.0%3.6 $1.02 10/15/2023170,200 shares $187.22 thousand +6.7%1.8%3 $1.10 9/30/2023159,500 shares $175.45 thousand -11.7%1.8%2.4 $1.10 9/15/2023180,600 shares $232.97 thousand -7.7%1.9%2.5 $1.29 8/31/2023195,700 shares $283.77 thousand -1.0%2.1%1.9 $1.45 8/15/2023197,600 shares $337.90 thousand -31.4%2.0%1.8 $1.71 7/31/2023288,000 shares $538.56 thousand +6.9%3.0%2.1 $1.87 7/15/2023269,500 shares $493.19 thousand +1.7%2.8%1.4 $1.83 6/30/2023264,900 shares $556.29 thousand +68.5%2.7%1.4 $2.10 6/15/2023157,200 shares $377.28 thousand +2.0%1.6%0.9 $2.40 5/31/2023154,100 shares $271.22 thousand -14.6%1.7%1.2 $1.76 5/15/2023180,500 shares $305.05 thousand +70.4%1.9%1.5 $1.69 4/30/2023105,900 shares $189.56 thousand +117.5%1.1%1.1 $1.79 4/15/202348,700 shares $107.63 thousand +34.2%1.1%2.8 $2.21 3/31/202336,300 shares $68.79 thousand -14.0%0.8%3.2 $1.90 3/15/202342,200 shares $84.82 thousand +92.7%1.0%3.6 $2.01 2/28/202321,900 shares $44.46 thousand -60.9%0.5%2.2 $2.03 2/15/202356,000 shares $112.56 thousand -19.4%1.3%4.6 $2.01 1/31/202369,500 shares $159.16 thousand -10.6%1.6%3.2 $2.29 1/15/202377,700 shares $183.37 thousand -15.2%1.7%3.4 $2.36 12/30/202291,600 shares $239.08 thousand -7.0%2.0%3.9 $2.61 12/15/202298,500 shares $217.69 thousand -34.9%2.1%4 $2.21 11/30/2022151,400 shares $401.21 thousand -7.4%3.3%5.2 $2.65 11/15/2022163,500 shares $501.67 thousand +24.0%3.5%4.6 $3.07 10/31/2022131,900 shares $287.54 thousand +3.2%2.8%0.3 $2.18 10/15/2022127,800 shares $241.54 thousand -0.8%2.8%0.3 $1.89 9/30/2022128,800 shares $271.77 thousand +25.1%2.8%0.3 $2.11 9/15/2022103,000 shares $269.86 thousand -46.1%2.2%0.2 $2.62 8/31/2022191,200 shares $502.86 thousand +15.3%4.2%0.4 $2.63 8/15/2022165,800 shares $563.72 thousand +400.9%3.7%0.4 $3.40 7/31/202233,100 shares $43.36 thousand +0.3%0.8%0.8 $1.31 7/15/202233,000 shares $42.57 thousand -35.6%0.8%0.8 $1.29 6/30/202251,200 shares $72.19 thousand -57.2%1.2%0.9 $1.41 6/15/2022119,500 shares $223.47 thousand -1.6%2.9%2 $1.87 5/31/2022121,400 shares $188.17 thousand +33.6%2.9%2 $1.55 5/15/202290,900 shares $117.26 thousand -16.0%2.2%1.4 $1.29 4/30/2022108,200 shares $242.37 thousand -32.5%2.6%1.7 $2.24 4/15/2022160,400 shares $469.97 thousand +5.0%3.8%2.2 $2.93 3/31/2022152,800 shares $343.80 thousand -2.4%3.7%2 $2.25 3/15/2022156,500 shares $355.26 thousand -7.6%3.8%1.9 $2.27 2/28/2022169,400 shares $503.12 thousand +5.2%4.2%1.9 $2.97 2/15/2022161,000 shares $457.24 thousand -21.8%4.0%1.7 $2.84 1/31/2022205,800 shares $677.08 thousand -11.3%5.1%2.2 $3.29 1/15/2022231,900 shares $735.12 thousand +139.1%N/A2.2 $3.17 12/31/202197,000 shares $432.62 thousand No Change2.4%0.9 $4.46 INKT Short Interest - Frequently Asked Questions What is MiNK Therapeutics' current short interest? Short interest is the volume of MiNK Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 48,600 shares of INKT short. 4.42% of MiNK Therapeutics' shares are currently sold short. Learn More on MiNK Therapeutics' current short interest. What is a good short interest percentage for MiNK Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.42% of MiNK Therapeutics' floating shares are currently sold short. Is MiNK Therapeutics' short interest increasing or decreasing? MiNK Therapeutics saw a drop in short interest in August. As of August 31st, there was short interest totaling 48,600 shares, a drop of 32.9% from the previous total of 72,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MiNK Therapeutics' float size? MiNK Therapeutics currently has issued a total of 4,520,000 shares. Some of MiNK Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MiNK Therapeutics currently has a public float of 1,100,000 shares. How does MiNK Therapeutics' short interest compare to its competitors? 4.42% of MiNK Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to MiNK Therapeutics: Candel Therapeutics, Inc. (19.24%), DBV Technologies S.A. (0.07%), Allogene Therapeutics, Inc. (10.35%), Editas Medicine, Inc. (8.88%), Replimune Group, Inc. (25.10%), Lyell Immunopharma, Inc. (1.69%), Kyverna Therapeutics, Inc. (6.33%), Cartesian Therapeutics, Inc. (28.00%), Alpha Teknova, Inc. (25.26%), Organigram Global Inc. (5.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.23 billion), Invesco QQQ ($29.52 billion), iShares Russell 2000 ETF ($20.82 billion), iShares 20+ Year Treasury Bond ETF ($10.76 billion), Palo Alto Networks, Inc. ($9.37 billion), Strategy Inc ($7.58 billion), Invesco S&P 500 Equal Weight ETF ($6.78 billion), SPDR S&P Biotech ETF ($6.72 billion), AppLovin Corporation ($6.37 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.29 billion). View all of the most shorted stocks. What does it mean to sell short MiNK Therapeutics stock? Short selling INKT is an investing strategy that aims to generate trading profit from MiNK Therapeutics as its price is falling. INKT shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MiNK Therapeutics? A short squeeze for MiNK Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INKT, which in turn drives the price of the stock up even further. How often is MiNK Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INKT, twice per month. The most recent reporting period available is August, 31 2025. More Short Interest Resources from MarketBeat Related Companies CADL Short Interest DBVT Short Interest ALLO Short Interest EDIT Short Interest REPL Short Interest LYEL Short Interest KYTX Short Interest RNAC Short Interest TKNO Short Interest OGI Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INKT) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
